Filing Details
- Accession Number:
- 0001213900-25-046087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-20 18:03:12
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-20
- Accepted Time:
- 2025-05-20 18:03:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1658369 | Maged Shenouda | C/O Relmada Therapeutics, Inc. 2222 Ponce De Leon Blvd, 3Rd Floor Coral Gables FL 33134 | Chief Financial Officer | No | Yes | No | No |
Transaction Summary
Purchased: | 200,000 shares | Avg. Price: $0.49 | Total Value: $97,208.00 |
Number of Shares After Transactions: | 288,335 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-16 | 50,000 | $0.44 | 138,335 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-05-19 | 90,000 | $0.49 | 228,335 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-05-20 | 60,000 | $0.52 | 288,335 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- Purchase prices range from $0.4229 to $0.4674 per share, inclusive.
- Purchase prices range from $0.4493 to $0.4998 per share, inclusive.
- Purchase prices range from $0.4998 to $0.5396 per share, inclusive.